Skip to content
Beacon

RXDProShares UltraShort Health Care

Take a bet19y track recordRanked #527 of 775 in this goal

Seeks daily investment results of -200% of the daily performance of the S&P Health Care Select Sector Index.

By ProShares · Launched 2007

Annual Cost

0.95%

#4,684 of 5,562 · expensive

Fund Size

$5M

#5,045 of 5,562 · small

Return (1Y)Goal

-19.6%

Track Record

19 years

#427 of 5,562 · established

Performance

Total-return NAV · USD
Growth of $10,000
$7,721-22.8%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Inverse

Sector

Health care

Index tracked

S&P Health Care Select Sector Index

What it actually holds

By weight

Concentration

Top 10 holdings = 104.5% of fundconcentrated

Repurchase Agreement
28.6%
Repurchase Agreement
19.9%
Repurchase Agreement
17.3%
N/A
7.2%
Repurchase Agreement
6.9%
Repurchase Agreement
6.9%
Repurchase Agreement
5.2%
Repurchase Agreement
5.2%
N/A
3.8%
Repurchase Agreement
3.4%

Asset allocation

Cash
200.0%
Other
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
30.1%High

Year-on-year price swings

Max drawdown
-90.6%Severe

Worst peak-to-trough loss

Sharpe (3Y)
-0.18Below average
Sortino (3Y)
-0.26Moderate downside risk

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks daily investment results of -200% of the daily performance of the S&P Health Care Select Sector Index.
Strategy
Invests primarily in financial instruments to achieve inverse leveraged exposure to the Index. Uses derivatives like swap agreements and may hold money market instruments for cash balances. The portfolio is rebalanced daily to maintain consistent exposure to the Daily Target.
Inception date
January 30, 2007
Fund family
ProShares

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Inverse
Warning

Inverse ETF — daily tool only

Delivers the inverse of the benchmark's daily return. The compounding path makes multi-day holding unpredictable even when the benchmark's total move goes your way. Legitimate as a one-day hedge; dangerous as a view.

Source: Cheng & Madhavan (2009)

Why we flagged this: strategy=inverse + inverse_name_or_strategy

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed RXD. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-20